Search Results1-9 of  9

  • Yasui Hisateru ID: 9000329006870

    Articles in CiNii:1

    • Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer (2016)
  • Yasui Hisateru ID: 9000361229967

    Articles in CiNii:1

    • Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase Ⅲ study of S-1 plus oxaliplatin versus S-1 plus cisplatin (2017)
  • Yasui Hisateru ID: 9000399574854

    Articles in CiNii:1

    • Early tumor shrinkage and depth of response in patients with advanced gastric cancer : a retrospective analysis of a randomized phase Ⅲ study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin (2019)
  • Hisateru Yasui ID: 9000408572337

    Articles in CiNii:1

    • Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer (2019)
  • YASUI Hisateru ID: 9000001122301

    Gastrointestinal Oncology Division, National Cancer Center Hospital (2003 from CiNii)

    Articles in CiNii:1

    • Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer (2003)
  • Yasui Hisateru ID: 9000243886269

    Department of Medical Oncology, National Hospital Organization Kyoto Medical Center (2013 from CiNii)

    Articles in CiNii:1

    • Secondary Pneumothorax in a Patient with Pulmonary Metastasis of Myxofibrosarcoma During the Administration of Pazopanib (2013)
  • Yasui Hisateru ID: 9000378649654

    Department of Medical Oncology, National Hospital Organization Kyoto Medical Center, Kyoto, Kyoto, Japan (2018 from CiNii)

    Articles in CiNii:1

    • Pazopanib-mediated Long-term Disease Stabilization after Local Recurrence and Distant Metastasis of Primary Intracranial Leiomyosarcoma: A Case Report on the Efficacy of Pazopanib as a Salvage Therapy (2018)
  • Yasui Hisateru ID: 9000402241340

    Department of Medical Oncology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Japan (2019 from CiNii)

    Articles in CiNii:1

    • Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with <i>ALK</i> mutation (2019)
  • Yasui Hisateru ID: 9000405104600

    Department of Medical Oncology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Japan (2019 from CiNii)

    Articles in CiNii:1

    • Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine (2019)
Page Top